In vivo effect of minocycline alone and in combination with immunotherapy against pythium insidiosum.
Fungistatic activity
Immunotherapy
Minocycline
Pitium-Vac®
Pythiosis
Journal
Veterinary microbiology
ISSN: 1873-2542
Titre abrégé: Vet Microbiol
Pays: Netherlands
ID NLM: 7705469
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
received:
26
07
2019
revised:
16
02
2020
accepted:
20
02
2020
entrez:
11
4
2020
pubmed:
11
4
2020
medline:
25
11
2020
Statut:
ppublish
Résumé
This study examined the effect of minocycline alone and in combination with immunotherapy against pythiosis. Twenty rabbits, aged three months old and subcutaneously inoculated with Pythium insidiosum zoospores were divided into four groups (n = 5): treated with minocycline (10 mg/kg/day twice daily), treated with immunotherapy (34 mg subcutaneously every 14 days), treated with minocycline plus immunotherapy, and untreated (control group). The treatments were started 30 days after inoculation and continued for 70 days. The subcutaneous nodular injury areas in infected groups were measured every seven days after the beginning of treatment. Only the rabbits that developed lesions were selected for this study. When compared with the control group over 70 days, the minocycline and minocycline plus immunotherapy groups of rabbits with pythiosis showed significantly reduced injuries. The histopathology showed the presence of inflammation, macrophages and eosinophils. Grocott's staining revealed irregular hyphae-like structures that were ramified and occasionally septate. Our results suggest that minocycline has fungistatic activity and that the combination of minocycline and immunotherapy is more effective than the individual therapies tested.
Identifiants
pubmed: 32273002
pii: S0378-1135(19)30880-6
doi: 10.1016/j.vetmic.2020.108616
pii:
doi:
Substances chimiques
Minocycline
FYY3R43WGO
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
108616Informations de copyright
Copyright © 2020. Published by Elsevier B.V.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that there are no conflicts of interest in this manuscript either via financial or personal relationships with other people or organizations that could inappropriately influence the content of this work.